Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) Gross Profit: 2019-2025

Historic Gross Profit for Burning Rock Biotech (BNR) over the last 7 years, with Sep 2025 value amounting to -$162.8 million.

  • Burning Rock Biotech's Gross Profit fell 14.43% to -$162.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $137.5 million, marking a year-over-year increase of 170.48%. This contributed to the annual value of $49.6 million for FY2024, which is 2.96% down from last year.
  • Burning Rock Biotech's Gross Profit amounted to -$162.8 million in Q3 2025, which was down 184.73% from $192.1 million recorded in Q2 2025.
  • Burning Rock Biotech's Gross Profit's 5-year high stood at $192.1 million during Q2 2025, with a 5-year trough of -$234.0 million in Q4 2023.
  • Moreover, its 3-year median value for Gross Profit was $85.7 million (2024), whereas its average is $13.0 million.
  • Per our database at Business Quant, Burning Rock Biotech's Gross Profit plummeted by 1,417.29% in 2022 and then spiked by 766.38% in 2023.
  • Burning Rock Biotech's Gross Profit (Quarterly) stood at $17.0 million in 2021, then crashed by 1,417.29% to -$223.7 million in 2022, then fell by 4.60% to -$234.0 million in 2023, then surged by 104.59% to $10.7 million in 2024, then dropped by 14.43% to -$162.8 million in 2025.
  • Its Gross Profit stands at -$162.8 million for Q3 2025, versus $192.1 million for Q2 2025 and $97.4 million for Q1 2025.